Market Research Logo

EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025

EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025

Summary

Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), is a condition characterized by difficulty in breathing, shortness of breath, wheezing, chest tightness, and other respiratory symptoms that progress over time. The disease is often caused by smoking; however, long-term exposure to other lung irritants, such as pollution, smoke from vehicle emissions and power stations, chemical fumes, and dust, can also lead to the development of COPD (NHLBI, 2013).

In the 8MM, epidemiologists forecast that the total prevalent cases of COPD will increase from 65,991,432 cases in 2015 to 76,066,482 cases in 2025 at an Annual Growth Rate (AGR) of 1.53%. The US will have the highest number of total prevalent cases of COPD among the 8MM throughout the forecast period with 33,028,213 cases in 2015 and 39,284,075 cases in 2025.The US had the highest number of diagnosed prevalent cases of COPD in the 8MM in both 2015 and 2025, at 13,791,975 cases in 2015, and 16,033,432 cases in 2025.

The report EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025 provides an overview of the risk factors, comorbidities, and the global and historical trends for COPD in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the total prevalent cases of COPD (diagnosed and undiagnosed cases) and the diagnosed prevalent cases of COPD, which are segmented by sex and age (35-44, 45-54, 55-64, 65-74, and 75 years and older).

Scope

  • The Chronic obstructive pulmonary disease (COPD) EpiCast Report provides an overview of the risk factors and global trends of COPD in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the total prevalent cases of COPD (diagnosed and undiagnosed cases) and the diagnosed prevalent cases of COPD, which are segmented by sex and age (35-44, 45-54, 55-64, 65-74, and 75 years and older). The diagnosed prevalent cases of COPD are further segmented by the new GOLD 2011 severity stage (GOLD A, GOLD B, GOLD C, and GOLD D) using the COPD Assessment Test (CAT) scores and the modified Medical Research Council (mMRC) dyspnea scores.
  • The COPD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to buy

The COPD EpiCast report will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global COPD market.
  • Quantify patient populations in the global COPD market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for COPD therapeutics in each of the markets covered.
  • Understand severity stages of COPD cases by CAT score and mMRC scores.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Chronic Obstructive Pulmonary Disease: Executive Summary
2.1 Related Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Total Prevalent Cases
3.4.4 Diagnosed Prevalent Cases
3.4.5 Diagnosed Prevalent Cases of COPD by Severity
3.5 Epidemiological Forecast for COPD (2015-2025)
3.5.1 Total Prevalent Cases of COPD
3.5.2 Age-Specific Total Prevalent Cases of COPD
3.5.3 Sex-Specific Total Prevalent Cases of COPD
3.5.4 Diagnosed Prevalent Cases of COPD
3.5.5 Age-Specific Diagnosed Prevalent Cases of COPD
3.5.6 Sex-Specific Diagnosed Prevalent Cases of COPD
3.5.7 Diagnosed Prevalent Cases of COPD by Severity
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for COPD
Table 2: New GOLD 2011 Criteria for COPD Severity Stages
Table 3: 8MM, Total Prevalent Cases of COPD, Both Sexes, Ages ≥35 Years, N, Selected Years 2015-2025
Table 4: 8MM, Age-Specific Total Prevalent Cases of COPD, Both Sexes, N, 2015.
Table 5: 8MM, Diagnosed Prevalent Cases of COPD, Both Sexes, Ages ≥35 Years, N, Selected Years 2015-2025
Table 6: 8MM, Age-Specific Diagnosed Prevalent Cases of COPD, Both Sexes, N, 2015
1.2 List of Figures
Figure 1: 8MM, Total Prevalent Cases of COPD, Both Sexes, Ages ≥35 Years, 2015 and 2025
Figure 2: 8MM, Diagnosed Prevalent Cases of COPD, Both Sexes, Ages ≥35 Years, 2015 and 2025
Figure 3: 8MM, Age-Standardized Total Prevalence of COPD (%), Ages ≥35 Years, 2015
Figure 4: 8MM, Age-Standardized Diagnosed Prevalence of COPD (%), Ages ≥35 Years, 2015
Figure 5: 8MM, Sources Used and Not Used to Forecast Total Prevalent Cases of COPD
Figure 6: 8MM, Sources Used and Not Used to Forecast Diagnosed Prevalent Cases of COPD
Figure 7: 8MM, Sources Used to Forecast the new GOLD 2011 Severity Stages Among the Diagnosed Prevalent Cases of COPD
Figure 8 : 8MM, Age-Specific Total Prevalent Cases of COPD, Both Sexes, N, 2015
Figure 9: 8MM, Sex-Specific Total Prevalent Cases of COPD, Both Sexes, N, 2015
Figure 10: 8MM, Age-Specific Diagnosed Prevalent Cases of COPD, Both Sexes, N, 2015
Figure 11: 8MM, Sex-Specific Diagnosed Prevalent Cases of COPD, Both Sexes, N, 2015
Figure 12: 8MM, Diagnosed Prevalent Cases of COPD by the GOLD Severity Stage (Using mMRC), Both Sexes, 2015
Figure 13: 8MM, Diagnosed Prevalent Cases of COPD by the GOLD Severity Stage (Using CAT), Both Sexes, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report